Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012)
- 1 February 2002
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 16 (3) , 486-488
- https://doi.org/10.1097/00002030-200202150-00023
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapyAIDS, 2001
- Dynamics of seminal plasma HIV-1 decline after antiretroviral treatmentAIDS, 2001
- Effect of Antiretroviral Therapy on HIV Shedding in SemenAnnals of Internal Medicine, 2000
- Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIVAIDS, 2000
- Residual HIV-1 RNA in Blood Plasma of Patients Taking Suppressive Highly Active Antiretroviral TherapyJAMA, 1999
- Persistence of Human Immunodeficiency Virus in Semen After Adding Indinavir to Combination Antiretroviral TherapyClinical Infectious Diseases, 1999
- Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapyNature Medicine, 1999
- Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmissionAIDS, 1999
- Human Immunodeficiency Virus Type 1 in the Semen of Men Receiving Highly Active Antiretroviral TherapyNew England Journal of Medicine, 1998
- Detection of Human Immunodeficiency Virus Type 1 in Semen: Effects of Disease Stage and Nucleoside TherapyThe Journal of Infectious Diseases, 1993